Tonghe Pharmaceutical announced that Pang Zhengwei, the controlling shareholder and one of the actual controllers, increased his holdings of the company's A shares by 611,800 through centralized transactions on October 8, 2026, accounting for 0.15% of the total share capital. The capital was his own capital. This increase in holdings is consistent with the previously disclosed increase plan. As of the announcement date, the plan had not yet been implemented; the total shareholding ratio of Pang Zhengwei and those who acted together rose from 28.91% to 29.05%.

Tonghe Pharmaceutical announced that Pang Zhengwei, the controlling shareholder and one of the actual controllers, increased his holdings of the company's A shares by 611,800 through centralized transactions on October 8, 2026, accounting for 0.15% of the total share capital. The capital was his own capital. This increase in holdings is consistent with the previously disclosed increase plan. As of the announcement date, the plan had not yet been implemented; the total shareholding ratio of Pang Zhengwei and those who acted together rose from 28.91% to 29.05%.